The most likely cause of this finding is that some genetic mutations, such as those in MYD88, CREBBP, BCL2, KMT2D, PIM1, and EZH2, rarely occur in GI-DLBCL. Here, MYD88 is linked to diffuse large B-cell lymphoma.